New strategy to attack aggressive brain cancer shows promise
Time:2024-05-22 02:19:37 Source:healthViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Auburn running back Brian Battie on ventilator after weekend shooting in Florida, coach says
Next:MPs' fury at 'virtue
You may also like
- Yu Darvish extends scoreless innings streak to 25 in Padres' 9
- Ernie Els, 5 others in 6
- Angelina Jolie is accused of sabotaging her six kids' relationship with Brad Pitt
- Djokovic wins his opener at the Italian Open after a month off. Defending champ Rybakina withdraws
- Ohio judge to rule Monday on whether the state’s abortion ban stands
- Last year's runner
- Inside a makeshift shelter saving hundreds of dogs from floods in southern Brazil
- Trump hush money trial: Michael Cohen awaits turn after graphic Stormy Daniels account
- Uber and Lyft say they'll stay in Minnesota after Legislature passes driver pay compromise